Status:
ENROLLING_BY_INVITATION
The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study
Lead Sponsor:
University of Edinburgh
Conditions:
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Eligibility:
All Genders
18-99 years
Brief Summary
To prospectively study novel blood and lung biomarkers of disease activity in patients with IPF and other interstitial lung disease with the aims of prognostic modelling and disease clustering
Detailed Description
BACKGROUND Idiopathic pulmonary fibrosis (IPF) is a progressive form of lung scarring for which there is no proven treatment. Steroids and other potentially toxic drugs are often used but their effic...
Eligibility Criteria
Inclusion
- patients with interstitial lung disease attending the Edinburgh Lung Fibrosis service
Exclusion
- candidates not a suitable for enrolment or unlikely to comply with the requirements of this study, in the opinion of the investigator, will be excluded.
Key Trial Info
Start Date :
June 14 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2036
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04016181
Start Date
June 14 2007
End Date
December 1 2036
Last Update
June 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.